person · Reporting owner

Bujarski Robert Joseph

Disclosed activity across 2 companies

Tapewire entity: 86707
SEC CIK: 0001333458

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
QuidelOrtho CorpQDEL · Entity 4986	EVP & COO	October 15, 2024	October 17, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QuidelOrtho Corp

Report date October 15, 2024 · Filed October 17, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	44,810	Ending reported balance After 2024-10-15 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2024-10-15 · Grant · Acquired 390 · Balance 45,027 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-10-15 · Tax withholding · Disposed 217 · Balance 44,810 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	390	Reported balance After 2024-10-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-10-15 · Exercise / conversion · Disposed 390 · Balance 390 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

QUIDEL CORP /DE/

Report date May 27, 2022 · Filed June 01, 2022

Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-05-27 transaction · row 1 1 source row Row 1 · 2022-05-27 · Disposition to issuer · Disposed 29,164 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $23.41 · Expires 2025-02-05	Direct	Reported balance After 2022-05-27 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-05-27 · Disposition to issuer · Disposed 8,798 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2026-02-10	Direct	Reported balance After 2022-05-27 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-05-27 · Disposition to issuer · Disposed 17,596 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $21.08 · Expires 2027-02-15	Direct	Reported balance After 2022-05-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-05-27 · Disposition to issuer · Disposed 14,343 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16	Direct	Reported balance After 2022-05-27 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-05-27 · Disposition to issuer · Disposed 9,212 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04	Direct	Reported balance After 2022-05-27 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-05-27 · Disposition to issuer · Disposed 7,246 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $77.16 · Expires 2030-02-03	Direct	Reported balance After 2022-05-27 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-05-27 · Disposition to issuer · Disposed 6,641 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $159.39 · Expires 2030-09-14	Direct	Reported balance After 2022-05-27 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-05-27 · Disposition to issuer · Disposed 2,935 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01	Direct	Reported balance After 2022-05-27 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-05-27 · Disposition to issuer · Disposed 3,514 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31	Direct	Reported balance After 2022-05-27 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-05-27 · Disposition to issuer · Disposed 12,876 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-05-27 · Disposition to issuer · Disposed 3,623 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 3,623 shares will vest on February 4, 2023.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2022-05-27 · Disposition to issuer · Disposed 2,749 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2022-05-27 · Disposition to issuer · Disposed 824 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2022-05-27 · Disposition to issuer · Disposed 1,033 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,033 shares will vest on November 18, 2022.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2022-05-27 · Disposition to issuer · Disposed 3,320 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2022-05-27 · Disposition to issuer · Disposed 1,052 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2022-05-27 · Disposition to issuer · Disposed 315 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2022-05-27 · Disposition to issuer · Disposed 941 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2022-05-27 · Disposition to issuer · Disposed 1,351 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2022-05-27 · Disposition to issuer · Disposed 405 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2022-05-27 · Disposition to issuer · Disposed 2,637 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · 2022-05-27 · Disposition to issuer · Disposed 12,878 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · 2022-05-27 · Disposition to issuer · Disposed 13,545 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · 2022-05-27 · Disposition to issuer · Disposed 1,190 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 26 Instrument identity requires review; Table II rows are not merged. 1 source row Row 26 · 2022-05-27 · Disposition to issuer · Disposed 357 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F20: 357 shares will vest on January 31, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3: Vested in full.

F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.

F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.

F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.

F9: Each restricted stock unit represents the right to receive one share of Quidel common stock.

F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F11: 3,623 shares will vest on February 4, 2023.

F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F13: 1,033 shares will vest on November 18, 2022.

F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.

F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.

F20: 357 shares will vest on January 31, 2023.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	1,052	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 16 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052 Underlying: Common Stock · 1,052 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	3,320	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 15 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,320 Underlying: Common Stock · 3,320 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14 · derivative.exercise_date: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. F14 · derivative.expiration_date: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	1,033	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 14 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033 Underlying: Common Stock · 1,033 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13 · derivative.exercise_date: 1,033 shares will vest on November 18, 2022. F13 · derivative.expiration_date: 1,033 shares will vest on November 18, 2022. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	824	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 13 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 824 Underlying: Common Stock · 824 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	2,749	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 12 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,749 Underlying: Common Stock · 2,749 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F12 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantRestricted Stock Units · Derivative	3,623	$0.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 11 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,623 Underlying: Common Stock · 3,623 shares Expires not disclosed F9 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F10 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11 · derivative.exercise_date: 3,623 shares will vest on February 4, 2023. F11 · derivative.expiration_date: 3,623 shares will vest on February 4, 2023. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	12,876	$0.00 Strike: $103.36	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 10 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,876 Underlying: Common Stock · 12,876 shares Expires 2032-01-31 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8 · derivative.exercise_date: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	3,514	$0.00 Strike: $254.00	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 9 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,514 Underlying: Common Stock · 3,514 shares Expires 2031-02-01 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7 · derivative.exercise_date: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	2,935	$0.00 Strike: $159.39	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 8 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935 Underlying: Common Stock · 2,935 shares Expires 2030-09-14 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6 · derivative.exercise_date: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	6,641	$0.00 Strike: $77.16	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 7 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,641 Underlying: Common Stock · 6,641 shares Expires 2030-02-03 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5 · derivative.exercise_date: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	7,246	$0.00 Strike: $59.12	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,246 Underlying: Common Stock · 7,246 shares Expires 2029-02-04 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	9,212	$0.00 Strike: $46.41	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,212 Underlying: Common Stock · 9,212 shares Expires 2028-01-16 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: Vested in full. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	14,343	$0.00 Strike: $21.08	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,343 Underlying: Common Stock · 14,343 shares Expires 2027-02-15 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: Vested in full. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	17,596	$0.00 Strike: $15.40	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,596 Underlying: Common Stock · 17,596 shares Expires 2026-02-10 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: Vested in full. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantNon-Qualified Stock Options · Derivative	8,798	$0.00 Strike: $23.41	$0.00	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,798 Underlying: Common Stock · 8,798 shares Expires 2025-02-05 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: Vested in full. Read SEC document
May 27, 2022 Filed Jun 1, 2022 17:40 UTC	QuidelOrtho Corp QDEL · Entity 4986	GrantCommon Stock	29,164	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-020502 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,164 F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. Read SEC document
February 03, 2022 Filed Feb 7, 2022 19:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	1,660	$0.00	$0.00	Disclosure SEC source: 0001209191-22-007620 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,320 Underlying: Common Stock · 1,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.exercise_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. F4 · derivative.expiration_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
February 03, 2022 Filed Feb 7, 2022 19:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	873	$99.68	$87,020.64	Disclosure SEC source: 0001209191-22-007620 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,164 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 03, 2022 Filed Feb 7, 2022 19:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,660	$0.00	$0.00	Disclosure SEC source: 0001209191-22-007620 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,037 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 01, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	879	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · derivative · entry 8 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,637 Underlying: Common Stock · 879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F5 · derivative.exercise_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. F5 · derivative.expiration_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
February 01, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	463	$102.32	$47,374.16	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,377 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 01, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	879	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,840 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Premium) · Derivative	357	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · derivative · entry 7 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357 Underlying: Common Stock · 357 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F7 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F9 · derivative.exercise_date: The restricted stock units vest on January 31, 2023. F7 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F9 · derivative.expiration_date: The restricted stock units vest on January 31, 2023. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Converted) · Derivative	1,190	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,190 Underlying: Common Stock · 1,190 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F7 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F8 · derivative.exercise_date: The restricted stock units vest on January 31, 2022. F7 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F8 · derivative.expiration_date: The restricted stock units vest on January 31, 2022. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	13,545	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,545 Underlying: Common Stock · 13,545 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F6 · derivative.exercise_date: 6,772 shares vest on the second anniversary date of the grant date, January 31, 2024; 3,386 shares vest on the third anniversary date of the grant date, January 31, 2025; and 3,387 shares vest on the fourth anniversary date of the grant date, January 31, 2026. F6 · derivative.expiration_date: 6,772 shares vest on the second anniversary date of the grant date, January 31, 2024; 3,386 shares vest on the third anniversary date of the grant date, January 31, 2025; and 3,387 shares vest on the fourth anniversary date of the grant date, January 31, 2026. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	12,878	$0.00	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · derivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 Underlying: Common Stock · 12,878 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F5 · derivative.exercise_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. F5 · derivative.expiration_date: One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
January 31, 2022 Filed Feb 2, 2022 21:55 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Option · Derivative	12,876	$0.00 Strike: $103.36	$0.00	Disclosure SEC source: 0001209191-22-006633 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,876 Underlying: Common Stock · 12,876 shares Expires 2032-01-31 F3 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
January 16, 2022 Filed Jan 19, 2022 20:04 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	4,606	$0.00	$0.00	Disclosure SEC source: 0001209191-22-003874 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,606 shares Expires 2022-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. Read SEC document
January 16, 2022 Filed Jan 19, 2022 20:04 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	2,489	$114.88	$285,936.32	Disclosure SEC source: 0001209191-22-003874 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,961 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
January 16, 2022 Filed Jan 19, 2022 20:04 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	4,606	$0.00	$0.00	Disclosure SEC source: 0001209191-22-003874 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,450 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
November 18, 2021 Filed Nov 22, 2021 19:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	1,033	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066234 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033 Underlying: Common Stock · 1,033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 1,034 shares vested on the first anniversary date of the grant date, November 18, 2020. 1,033 shares vested on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. F4 · derivative.expiration_date: 1,034 shares vested on the first anniversary date of the grant date, November 18, 2020. 1,033 shares vested on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. Read SEC document
November 18, 2021 Filed Nov 22, 2021 19:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	513	$144.71	$74,236.23	Disclosure SEC source: 0001209191-21-066234 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,844 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
November 18, 2021 Filed Nov 22, 2021 19:56 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,033	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066234 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,357 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
October 15, 2021 Filed Oct 19, 2021 19:43 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	1,559	$0.00	$0.00	Disclosure SEC source: 0001209191-21-061037 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,559 Underlying: Common Stock · 1,559 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. F2 · derivative.expiration_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
September 14, 2021 Filed Sep 16, 2021 20:04 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	313	$0.00	$0.00	Disclosure SEC source: 0001209191-21-056493 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 941 Underlying: Common Stock · 313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 313 shares vested on September 14, 2021; 313 shares will will vest on the second anniversary date of the grant date, September 14, 2022; 314 shares will vest on the third anniversary date of the grant date, September 14, 2023; and 314 shares will vest on the fourth anniversary date of the grant date, September 14, 2024. F4 · derivative.expiration_date: 313 shares vested on September 14, 2021; 313 shares will will vest on the second anniversary date of the grant date, September 14, 2022; 314 shares will vest on the third anniversary date of the grant date, September 14, 2023; and 314 shares will vest on the fourth anniversary date of the grant date, September 14, 2024. Read SEC document
September 14, 2021 Filed Sep 16, 2021 20:04 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	156	$146.35	$22,830.60	Disclosure SEC source: 0001209191-21-056493 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,324 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
September 14, 2021 Filed Sep 16, 2021 20:04 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	313	$0.00	$0.00	Disclosure SEC source: 0001209191-21-056493 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,480 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 18, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	1,797	$210.10	$377,549.70	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 8 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,167 F4 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document
February 18, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	3,623	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 7 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,964 F5 · shares: Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 02/04/2019. Read SEC document
February 18, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	2,284	$210.10	$479,868.40	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,341 F4 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document
February 18, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	4,606	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F3 · shares: Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 01/16/2018. Read SEC document
February 17, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units (Premium) · Derivative	1,094	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · derivative · entry 10 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.expiration_date: The shares of common stock issued pursuant to the release of these restricted stock units were released pursuant to deferral periods defined under the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document
February 17, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units (Converted) · Derivative	3,646	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · derivative · entry 9 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.expiration_date: The shares of common stock issued pursuant to the release of these restricted stock units were released pursuant to deferral periods defined under the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document
February 17, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	543	$217.79	$118,259.97	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,019 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 17, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,094	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,562 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 17, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	1,723	$217.79	$375,252.17	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,468 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 17, 2021 Filed Feb 19, 2021 19:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	3,646	$0.00	$0.00	Disclosure SEC source: 0001209191-21-012563 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,191 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 15, 2021 Filed Feb 17, 2021 20:31 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	7,172	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011584 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,172 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 7,172 shares vested on the fourth anniversary date of the grant date, February 15, 2021. F4 · derivative.expiration_date: 7,172 shares vested on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document
February 15, 2021 Filed Feb 17, 2021 20:31 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	3,556	$227.97	$810,661.32	Disclosure SEC source: 0001209191-21-011584 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,545 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 15, 2021 Filed Feb 17, 2021 20:31 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	7,172	$0.00	$0.00	Disclosure SEC source: 0001209191-21-011584 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,101 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.